Danish parallel importers and the Danish Medicines Agency have withdrawn a batch of Xeplion 150 mg from hospital pharmacies and 26 private pharmacies due to suspicion of falsification. On the basis of the available data, the Danish Medicines Agency assesses that the patient risk is low.
14 July 2017Adverse reaction reports received from the Danish Patient Compensation Association
06 July 2017The European Commission's decision concerning veterinary medicinal products containing zinc oxide
03 July 2017New fees for medicinal products, pharmaceutical companies and clinical trials from 1 July 2017